ArticleBMC public health2025
Preventive insights and practices of female health professionals regarding cervical cell dysplasia: a cross-sectional study in Egypt.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epidemiology of Human Papillomavirus in the Middle East and North Africa: A Review of Genotypic Prevalence, Vaccination Challenges, and Non-Cervical Clinical Outcomes.Diseases (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical dysplasia is preventable through screening methods and Human Papillomavirus (HPV) vaccination. Cervical cancer (CC) mortality is disproportionately higher in low-and-middle-income nations, which lack a population-based screening program. Health professionals should promptly counsel and educate females about cervical dysplasia prevention.
aimthis work aimed to determine the level of knowledge, attitudes, and practices of female health professionals about cervical cell dysplasia. As well as addressing the potential barriers against routine cytological screening tests.
methodsA cross-sectional multicentric study at two tertiary hospitals; Tanta and Menoufia University Hospitals, recruited 1300 women (physicians, nurses, pharmacists, and dentists) via a multistage stratified random sampling technique. A self-administered questionnaire consisting of 4 sections was used to collect the relevant data.
resultsAcross all professions, 25% and 49.2% respectively had good knowledge levels and positive attitudes regarding cervical dysplasia. The majority had not been vaccinated against HPV nor undergone a Pap smear. Older age, urban residence, and positive family history were significant predictors of negative attitudes towards screening, p < 0.0001, beta 95%(CI) = -0.8 ( -0.1,-0.05), -0.9 (-1.2,-0.6), -0.2 (-0.8,0.4)) respectively. The most encountered barriers opposing screening included lack of awareness about health facilities providing CC screening and the belief that there is no need so far, no complaints (72.6%,73%).
conclusionFemale health professionals possessed acceptable knowledge and relatively positive attitudes regarding CC prevention, while their practices were discouraging. Believing that CC is a curse was the main culprit of refraining screening. It is pivotal to enhance accessibility to cervical screening services in various healthcare settings and boost the knowledge of health practitioners as they are key promoters of public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.